These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 31524038)

  • 1. Modulators of platelet function in aging.
    Iyer KS; Dayal S
    Platelets; 2020 May; 31(4):474-482. PubMed ID: 31524038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet dysfunction in vascular pathologies and how can it be treated.
    Alexandru N; Popov D; Georgescu A
    Thromb Res; 2012 Feb; 129(2):116-26. PubMed ID: 22035630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet biology and functions: new concepts and clinical perspectives.
    van der Meijden PEJ; Heemskerk JWM
    Nat Rev Cardiol; 2019 Mar; 16(3):166-179. PubMed ID: 30429532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet Function in Cardiovascular Disease: Activation of Molecules and Activation by Molecules.
    Khodadi E
    Cardiovasc Toxicol; 2020 Feb; 20(1):1-10. PubMed ID: 31784932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging-related alterations in mechanistic target of rapamycin signaling promote platelet hyperreactivity and thrombosis.
    Portier I; Manne BK; Kosaka Y; Tolley ND; Denorme F; Babur Ö; Reddy AP; Wilmarth PA; Aslan JE; Weyrich AS; Rondina MT; Campbell RA
    J Thromb Haemost; 2024 Sep; 22(9):2576-2588. PubMed ID: 38849085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age associated non-linear regulation of redox homeostasis in the anucleate platelet: Implications for CVD risk patients.
    Jain K; Tyagi T; Patell K; Xie Y; Kadado AJ; Lee SH; Yarovinsky T; Du J; Hwang J; Martin KA; Testani J; Ionescu CN; Hwa J
    EBioMedicine; 2019 Jun; 44():28-40. PubMed ID: 31130473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrogen peroxide promotes aging-related platelet hyperactivation and thrombosis.
    Dayal S; Wilson KM; Motto DG; Miller FJ; Chauhan AK; Lentz SR
    Circulation; 2013 Mar; 127(12):1308-16. PubMed ID: 23426106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of oxidative stress on platelet hyperreactivity during aging.
    Fuentes E; Palomo I
    Life Sci; 2016 Mar; 148():17-23. PubMed ID: 26872977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelets, inflammation and anti-inflammatory effects of antiplatelet drugs in ACS and CAD.
    Müller KA; Chatterjee M; Rath D; Geisler T
    Thromb Haemost; 2015 Aug; 114(3):498-518. PubMed ID: 26224127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of P2Y₁₂ receptor and activated platelets during inflammation.
    Liverani E; Kilpatrick LE; Tsygankov AY; Kunapuli SP
    Curr Drug Targets; 2014; 15(7):720-8. PubMed ID: 24845219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Platelet inhibition and activation. Mechanisms and clinical implications].
    Alberio L; Clemetson KJ
    Herz; 2005 May; 30(3):176-80. PubMed ID: 15902367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspective: Tyrosine phosphatases as novel targets for antiplatelet therapy.
    Tautz L; Senis YA; Oury C; Rahmouni S
    Bioorg Med Chem; 2015 Jun; 23(12):2786-97. PubMed ID: 25921264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Platelet Activation and Oxidative Stress in the Evolution of Myocardial Infarction.
    Fuentes E; Moore-Carrasco R; de Andrade Paes AM; Trostchansky A
    J Cardiovasc Pharmacol Ther; 2019 Nov; 24(6):509-520. PubMed ID: 31280622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2Y12 Receptor Inhibitor for Antiaggregant Therapies: From Molecular Pathway to Clinical Application.
    Nappi F
    Int J Mol Sci; 2024 Jul; 25(14):. PubMed ID: 39062819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activation in essential hypertension: implications for antiplatelet treatment.
    Gkaliagkousi E; Passacquale G; Douma S; Zamboulis C; Ferro A
    Am J Hypertens; 2010 Mar; 23(3):229-36. PubMed ID: 20094035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents.
    Natarajan A; Zaman AG; Marshall SM
    Diab Vasc Dis Res; 2008 Jun; 5(2):138-44. PubMed ID: 18537103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maresin 1 induces a novel pro-resolving phenotype in human platelets.
    Lannan KL; Spinelli SL; Blumberg N; Phipps RP
    J Thromb Haemost; 2017 Apr; 15(4):802-813. PubMed ID: 28079976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet Signaling and Disease: Targeted Therapy for Thrombosis and Other Related Diseases.
    Yeung J; Li W; Holinstat M
    Pharmacol Rev; 2018 Jul; 70(3):526-548. PubMed ID: 29925522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet toll-like receptors in thromboinflammation.
    D' Atri LP; Schattner M
    Front Biosci (Landmark Ed); 2017 Jun; 22(11):1867-1883. PubMed ID: 28410150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.